ORIC PHARMACEUTICALS, INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-07-30: Form 8-K; Exhibit 10.1; Description Amended and Restated 2022 Inducement Equity Incentive Plan, and form agreements thereunder..
- 2026-06-22: Form 8-K; Exhibit 10.1; Description Amended and Restated 2020 Equity Incentive Plan and forms of agreements thereunder.
- 2026-02-23: Form 10-K; Exhibit 10.10; Description Amended and Restated Outside Director Compensation Policy.
- 2025-05-28: Form 8-K; Exhibit 10.1; Description Securities Purchase Agreement, dated May 23, 2025, by and among the Company and the Purchasers named therein..
| Filed | Form | Exhibit | Description |
|---|
| 2026-07-30 | 8-K | 10.1 | Amended and Restated 2022 Inducement Equity Incentive Plan, and form agreements thereunder. |
|---|
| 2026-06-22 | 8-K | 10.1 | Amended and Restated 2020 Equity Incentive Plan and forms of agreements thereunder |
|---|
| 2026-02-23 | 10-K | 10.10 | Amended and Restated Outside Director Compensation Policy |
|---|
| 2025-05-28 | 8-K | 10.1 | Securities Purchase Agreement, dated May 23, 2025, by and among the Company and the Purchasers named therein. |
|---|
| 2025-03-14 | 8-K | 10.1 | Amended and Restated 2022 Inducement Equity Incentive Plan, and form agreements thereunder. |
|---|
| 2025-02-18 | 10-K | 10.10 | Amended and Restated Outside Director Compensation Policy |
|---|
| 2024-05-06 | 10-Q | 10.2 | Amended and Restated Outside Director Compensation Policy |
|---|
| 2024-05-06 | 10-Q | 10.1 | Amendment No.1 to the License and Collaboration Agreement by and between the Registrant and Voronoi Inc., effective March 20, 2024 |
|---|
| 2024-03-29 | 8-K | 10.1 | Amended and Restated 2022 Inducement Equity Incentive Plan, and form agreements thereunder. |
|---|
| 2024-01-22 | 8-K | 10.1 | Stock Purchase Agreement, dated January 20, 2024, by and among the Company and the Purchasers named therein. |
|---|
| 2023-06-27 | 8-K | 10.1 | Securities Purchase Agreement, dated June 24, 2023, by and among the Company and the Purchasers named therein. |
|---|
| 2022-05-09 | 10-Q | 10.3 | License and Collaboration Agreement between the registrant and Voronoi, Inc., dated as of October 19, 2020. |
|---|
| 2022-05-09 | 10-Q | 10.2 | License Agreement between the registrant and Mirati Therapeutics, Inc., dated as of August 3, 2020. |
|---|
| 2022-03-21 | 10-K | 10.10 | Amended and Restated Outside Director Compensation Policy |
|---|
| 2022-03-04 | 8-K | 10.1 | 2022 Inducement Equity Incentive Plan and related forms of stock option and restricted stock unit agreements. |
|---|
| 2021-11-08 | 10-Q | 10.2 | 2020 Employee Stock Purchase Plan and forms of agreement thereunder |
|---|
| 2021-08-16 | 8-K | 10.1 | First Amendment to Lease between the Registrant and Britannia Pointe Grand Limited Partnership, dated August 12, 2021. |
|---|